C4BPA and biliary tract neoplasm: To further assess the ability of C4BPA as a specific biomarker for PDAC, the researchers also compared the serum levels of C4BPA in comparison with CA 19-9 in other types of gastroenterological malignancies (e.g., biliary tract cancer).